Aqueous suspensions of TMC278

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11389447
APP PUB NO 20160089369A1
SERIAL NO

14964297

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention concerns pharmaceutical compositions for administration via intramuscular or subcutaneous injection, comprising micro- or nanoparticles of the NNRTI compound TMC278, suspended in an aqueous pharmaceutically acceptable carrier, and the use of such pharmaceutical compositions in the treatment and prophylaxis of HIV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN SCIENCES IRELAND UNLIMITED COMPANYBARNAHELY RINGASKIDDY CORK

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baert, Lieven Elvire Colette Bruges, BE 34 91
Dries, Willy Albert Maria Carlo Merksplas, BE 2 1
Francois, Marc Karel Jozef Kapellen, BE 11 236
Schueller, Laurent Bruno Antwerp, BE 4 3
Van, Remoortere Peter Jozef Maria Kapellen, BE 8 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 19, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 19, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 19, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00